Skip to content

Jean-Paul Leva, D.O.

NPI 1689037392ActiveIndividual· Surgery· Elmhurst, NY

Surgery (D.O.) in Elmhurst, New York, licensed in NY, with an NPI issued in March 2016. Part D covered 74 prescriptions written in 2024, 96% of them generic. Revance Therapeutics, Inc. was the largest of 2 companies reporting payments in 2025, $151.89 in all, mostly food and beverage.

Overview

NPI1689037392
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorNo
NPI issuedMar 30, 2016
Last updated in NPPESOct 29, 2022
Certified by providerOct 29, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Surgery Primary208600000X296879NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)74 · 75 30-day fills
Patients24
Total drug cost$521.85
Generic share96% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$151.89 · 2 payments from 2 companies
  • 2024$201.80 · 3 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$151.89 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery providers in Elmhurst

All Surgery providers in New York →